Crestwood Advisors Group LLC Vertex Pharmaceuticals Inc Transaction History
Crestwood Advisors Group LLC
- $5.4 Billion
- Q2 2025
A detailed history of Crestwood Advisors Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 10,043 shares of VRTX stock, worth $3.89 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
10,043
Previous 10,275
2.26%
Holding current value
$3.89 Million
Previous $4.98 Million
10.24%
% of portfolio
0.08%
Previous 0.1%
Shares
16 transactions
Others Institutions Holding VRTX
# of Institutions
1,810Shares Held
239MCall Options Held
1.95MPut Options Held
1.12M-
Capital World Investors Los Angeles, CA28.7MShares$11.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.25 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.57 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.5B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...